TI
AZN icon

Tidal Investments’s AstraZeneca AZN Stock Holding History

Tidal Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.6M Buy
248,108
+31,379
+14% +$5.9M 0.08% 244
2026
Q1 		$42.2M Buy
216,729
+205,657
+1,857% +$39.7M 0.09% 205
2025
Q4 		$2.04M Sell
11,072
-27,035
-71% -$4.74M ﹤0.01% 945
2025
Q3 		$5.85M Buy
38,107
+30,706
+415% +$4.65M 0.01% 559
2025
Q2 		$1.03M Buy
7,401
+806
+12% +$113K 0.01% 1021
2025
Q1 		$969K Buy
6,595
+2,953
+81% +$427K 0.01% 987
2024
Q4 		$477K Buy
3,642
+317
+10% +$44.4K ﹤0.01% 1411
2024
Q3 		$518K Buy
3,325
+181
+6% +$29.2K 0.01% 1367
2024
Q2 		$490K Buy
3,144
+727
+30% +$109K 0.01% 1318
2024
Q1 		$327K Buy
+2,417
New +$320K 0.01% 1367
2023
Q3 		– Sell
-1,428
Closed -$204K – 1300
2023
Q2 		$204K Buy
+1,428
New +$210K 0.01% 1205

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tidal Investments's AZN Position: Q2 2026 in Review

Tidal Investments increased its AstraZeneca (AZN) stake by 14% in Q2 2026, buying an estimated $5.9M and bringing the position to 248,108 shares worth $46.6M. The position accounts for 0.08% of the portfolio, ranked #244.

Tidal Investments first reported a position in AZN in Q2 2023 and has held it in 11 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Tidal Investments held 248,108 shares of AstraZeneca worth $46.6M as of Q2 2026.
  • Tidal Investments bought 31,379 AstraZeneca shares in Q2 2026, an estimated $5.9M.
  • AstraZeneca made up 0.08% of Tidal Investments's portfolio in Q2 2026, its #244 holding.
  • Tidal Investments first reported a position in AstraZeneca in Q2 2023 and has held it in 11 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.